(Q38874430)

English

Liquiritigenin Potentiates the Inhibitory Effects of Cisplatin on Invasion and Metastasis Via Downregulation MMP-2/9 and PI3 K/AKT Signaling Pathway in B16F10 Melanoma Cells and Mice Model

scientific article published on 15 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Liquiritigenin Potentiates the Inhibitory Effects of Cisplatin on Invasion and Metastasis Via Downregulation MMP-2/9 and PI3 K/AKT Signaling Pathway in B16F10 Melanoma Cells and Mice Model (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

based on heuristic

inferred from title

author name string

Hui Shi

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Yuchen Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Yang Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ming Zhou

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Shu Yan

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Zhimin Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Dawei Gu

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Yunqing Cai

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

15 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Nutrition and Cancer

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

67

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

761-770

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

The metastatic process: methodological advances and pharmacological challenges.

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Risk factors for the development of primary cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Tumor metastasis: mechanistic insights and clinical challenges

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Matrix metalloproteinases: multifunctional contributors to tumor progression

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

PI3-K/Akt/JNK/NF-κB is essential for MMP-9 expression and outgrowth in human limbal epithelial cells on intact amniotic membrane

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Alpha-chaconine-reduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-kappaB in human lung adenocarcinoma A549 cells

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Drugs five years later. Cisplatin

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients.

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Flavonoids and cancer prevention: a review of the evidence

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7.

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Cytotoxic flavonoids from Platymiscium floribundum

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Inhibitory effect of liquiritigenin on migration via downregulation proMMP-2 and PI3K/Akt signaling pathway in human lung adenocarcinoma A549 cells

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Matrix metalloproteinases in tumor invasion and metastasis

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

The emerging mechanisms of isoform-specific PI3K signalling

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Functional and therapeutic significance of Akt deregulation in malignant melanoma.

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2015.1037962

21 January 2018

Identifiers

10.1080/01635581.2015.1037962

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38874430&oldid=1792925422"